Menu

Folly Beach Library

Closed

Phone: (843) 588-2001

Edgar Allan Poe/Sullivan's Island Library

Closed for renovations

Phone: (843) 883-3914

West Ashley Library

9 a.m. – 7 p.m.

Phone: (843) 766-6635

Wando Mount Pleasant Library

9 a.m. – 8 p.m.

Phone: (843) 805-6888

Village Library

9 a.m. – 6 p.m.

Phone: (843) 884-9741

St. Paul's/Hollywood Library

9 a.m. – 8 p.m.

Phone: (843) 889-3300

Otranto Road Library

9 a.m. – 8 p.m.

Phone: (843) 572-4094

Mt. Pleasant Library

9 a.m. – 8 p.m.

Phone: (843) 849-6161

McClellanville Library

9 a.m. - 6 p.m.

Phone: (843) 887-3699

Keith Summey North Charleston Library

9 a.m. – 8 p.m.

Phone: (843) 744-2489

John's Island Library

9 a.m. – 8 p.m.

Phone: (843) 559-1945

Hurd/St. Andrews Library

9 a.m. – 8 p.m.

Phone: (843) 766-2546

Miss Jane's Building (Edisto Library Temporary Location)

9 a.m. – 6 p.m.

Phone: (843) 869-2355

Dorchester Road Library

9 a.m. – 8 p.m.

Phone: (843) 552-6466

John L. Dart Library

9 a.m. – 7 p.m.

Phone: (843) 722-7550

Baxter-Patrick James Island

9 a.m. – 8 p.m.

Phone: (843) 795-6679

Main Library

9 a.m. – 8 p.m.

Phone: (843) 805-6930

Bees Ferry West Ashley Library

9 a.m. – 8 p.m.

Phone: (843) 805-6892

Mobile Library

9 a.m. - 5 p.m.

Phone: (843) 805-6909

Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Your Filters

Format : Magazines Filter by : Subject

Item request has been placed!

Item request cannot be made.

Processing Request

Periodical

Accelerated approval of multiple myeloma therapies.

Authors : Nierengarten MB

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Drug Approval*

Source: Cancer [Cancer] 2024 Aug 15; Vol. 130 (16), pp. 2732.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142

Read More Add to Saved list

Periodical

FDA approves third anti-amyloid antibody for Alzheimer disease.

Authors : Mullard A

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/immunology ; Drug Approval*

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Aug; Vol. 23 (8), pp. 571.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Read More Add to Saved list

Periodical

FDA approves first telomerase inhibitor.

Authors : Mullard A

Subjects: Telomerase*/Telomerase*/Telomerase*/antagonists & inhibitors ; United States Food and Drug Administration* ; Drug Approval*

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Aug; Vol. 23 (8), pp. 570.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Read More Add to Saved list

Periodical

FDA approves 21-valent pneumococcal vaccine.

Authors : Mullard A

Subjects: Pneumococcal Vaccines* ; United States Food and Drug Administration* ; Drug Approval*

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Aug; Vol. 23 (8), pp. 572.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Read More Add to Saved list

Periodical

FDA approves mRNA-based RSV vaccine.

Authors : Mullard A

Subjects: United States Food and Drug Administration* ; Drug Approval* ; Respiratory Syncytial Virus Vaccines*/Respiratory Syncytial Virus Vaccines*/Respiratory Syncytial Virus Vaccines*/immunology

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Jul; Vol. 23 (7), pp. 487.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Read More Add to Saved list

Periodical

FDA approves first DLL3 × CD3 bispecific T-cell engager for lung cancer.

Authors : Mullard A

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/immunology ; United States Food and Drug Administration*

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Jul; Vol. 23 (7), pp. 487.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Read More Add to Saved list

Periodical

New Alzheimer's drug clears FDA advisory vote despite unknowns.

Authors : Couzin-Frankel J

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

Source: Science (New York, N.Y.) [Science] 2024 Jun 14; Vol. 384 (6701), pp. 1164-1165. Date of Electronic Publication: 2024 Jun 13.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic

Read More Add to Saved list

Periodical

Donanemab: FDA experts recommend approval of Alzheimer's drug.

Authors : Dyer O; Montreal.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Drug Approval* ; United States Food and Drug Administration*

Source: BMJ (Clinical research ed.) [BMJ] 2024 Jun 14; Vol. 385, pp. q1327. Date of Electronic Publication: 2024 Jun 14.Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN:

Read More Add to Saved list

Periodical

FDA approves first immunotherapy drug for nasopharyngeal carcinoma.

Authors : Nierengarten MB

Subjects: United States Food and Drug Administration* ; Drug Approval* ; Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/drug therapy

Source: Cancer [Cancer] 2024 Jun 01; Vol. 130 (11), pp. 1903.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142

Read More Add to Saved list

Periodical

CXCR4 chemokine antagonist scores a first FDA approval for WHIM syndrome.

Authors : Mullard A

Subjects: Receptors, CXCR4*/Receptors, CXCR4*/Receptors, CXCR4*/antagonists & inhibitors ; Drug Approval* ; United States Food and Drug Administration* WHIM syndrome

Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Jun; Vol. 23 (6), pp. 411.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Read More Add to Saved list